1. Home
  2. SNOA vs ASNS Comparison

SNOA vs ASNS Comparison

Compare SNOA & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • ASNS
  • Stock Information
  • Founded
  • SNOA 1999
  • ASNS 1998
  • Country
  • SNOA United States
  • ASNS United States
  • Employees
  • SNOA N/A
  • ASNS N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • ASNS Telecommunications Equipment
  • Sector
  • SNOA Health Care
  • ASNS Telecommunications
  • Exchange
  • SNOA Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • SNOA 6.4M
  • ASNS 5.5M
  • IPO Year
  • SNOA 2007
  • ASNS 2022
  • Fundamental
  • Price
  • SNOA $3.61
  • ASNS $0.59
  • Analyst Decision
  • SNOA
  • ASNS Strong Buy
  • Analyst Count
  • SNOA 0
  • ASNS 1
  • Target Price
  • SNOA N/A
  • ASNS $5.00
  • AVG Volume (30 Days)
  • SNOA 74.2K
  • ASNS 154.4K
  • Earning Date
  • SNOA 08-07-2025
  • ASNS 08-13-2025
  • Dividend Yield
  • SNOA N/A
  • ASNS N/A
  • EPS Growth
  • SNOA N/A
  • ASNS N/A
  • EPS
  • SNOA N/A
  • ASNS N/A
  • Revenue
  • SNOA $14,288,000.00
  • ASNS $7,755,000.00
  • Revenue This Year
  • SNOA $38.54
  • ASNS N/A
  • Revenue Next Year
  • SNOA N/A
  • ASNS $104.77
  • P/E Ratio
  • SNOA N/A
  • ASNS N/A
  • Revenue Growth
  • SNOA 12.20
  • ASNS 72.95
  • 52 Week Low
  • SNOA $1.75
  • ASNS $0.53
  • 52 Week High
  • SNOA $9.37
  • ASNS $2.21
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 62.41
  • ASNS 40.71
  • Support Level
  • SNOA $2.97
  • ASNS $0.55
  • Resistance Level
  • SNOA $3.04
  • ASNS $0.60
  • Average True Range (ATR)
  • SNOA 0.23
  • ASNS 0.04
  • MACD
  • SNOA 0.09
  • ASNS 0.00
  • Stochastic Oscillator
  • SNOA 59.71
  • ASNS 26.73

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: